Ionis Pharmaceuticals's total assets for Q1 2026 were $3.45B, a decrease of -2.10% from the previous quarter. IONS total liabilities were $2.96B for the fiscal quarter, a -2.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.